Pelizaeus-Merzbacher Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
The Plp1 overexpressing mouse model (PLP-tg<sup>66/66</sup> ) develops a phenotype very similar to human PMD, with early and severe motor dysfunction and a dramatic decrease in lifespan.
|
29027761 |
2018 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Additionally, a single intracerebroventricular injection of MO-PLP into the brains of neonatal mice, carrying a deletion of an intronic splicing enhancer identified in a PMD patient that reduces the Plp1 spliced form, corrected alternative splicing at both RNA and protein levels in the CNS.
|
30195779 |
2018 |
Pelizaeus-Merzbacher Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Characterization of a PLP-overexpressing transgenic rat, a model for the connatal form of Pelizaeus-Merzbacher disease.
|
21784154 |
2011 |
Pelizaeus-Merzbacher Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
A defective disulfide bond in PLP protein could be important in the pathogenesis of PMD.
|
21177054 |
2011 |
Pelizaeus-Merzbacher Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Our findings also point to unique pathological functions of the overexpressed PLP in PMD patients with duplication of this gene.
|
20637281 |
2010 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Gly197Arg is the first novel mutation located within exon 4 of the PLP gene and associated with mild PMD/SPG2 in a Japanese patient.
|
18783902 |
2009 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Genetic diagnosis of PLP gene duplications/deletions in patients with Pelizaeus-Merzbacher disease.
|
16207216 |
2005 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Pelizaeus-Merzbacher disease (PMD) is a dysmyelinating disease caused by mutations, deletions, or duplications of the proteolipid protein (PLP) gene.
|
15753308 |
2005 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
As only 10 - 30 % of patients with a Pelizaeus Merzbacher disease (PMD) phenotype carry mutations of the proteolipid protein (PLP) gene, we were interested if the degree and time-dependent progression of abnormal MRI and MRS findings would discriminate patients with mutations of the PLP gene (Pelizaeus Merzbacher disease, PMD) from patients without a defect of the PLP gene (Pelizaeus Merzbacher-like disease, PMLD).
|
12910435 |
2003 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Pelizaeus-Merzbacher disease (PMD) and a complicated form of familial spastic paraparesis (spastic paraplegia 2 [SPG2]) are X-linked development disorders of myelin formation caused by a mutation in the proteolipid protein (PLP) gene.Spastic paraplegia 2 is allelic to PMD.
|
12580714 |
2003 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Several naturally occurring and transgenic animal models with PLP gene mutations or deletions have contributed to our understanding of dysmyelination in PMD and the general knowledge of myelination and myelin repair.
|
12230321 |
2002 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A duplication of the whole PLP gene is the most common mutation and results usually in the milder classical phenotype, whereas point mutations in PLP gene often result in the rarer and more severe connatal form of PMD.
|
11786921 |
2002 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We focus on the increased dosage of the PLP gene that is the major cause of PMD and results from a submicroscopic duplication of Xq22.
|
11535114 |
2001 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The fetus, in common with the proband, was identified as PMD-affected being a carrier of the PLP gene duplication, inherited from the mother, while the two aunts were non-carriers.
|
11536268 |
2001 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in introns of the PLP gene, even at positions that are not 100% conserved at splice sites, are an important cause of PMD.
|
11071483 |
2000 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We conclude that the two cases are a rare type of dysmyelinating disorder with PMD phenotype of adult onset and could be caused by previously unrecognized abnormalities of the PLP gene or other genes.
|
10651021 |
2000 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Recent studies have shown that an increased PLP dosage, resulting from total duplication of the PLP gene, invariably causes the classic form of PMD.
|
10588103 |
2000 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
It has also emerged that duplications of the PLP gene are the commonest mutation in PMD.
|
10767322 |
2000 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Pelizaeus-Merzbacher disease (PMD) is an X-linked recessive disease caused by coding sequence mutations in the PLP gene, sub-microscopic duplications of variable sizes including the PLP gene or very rarely deletions of the PLP gene.
|
10878666 |
2000 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Different mutations in the same codon of the proteolipid protein gene, PLP, may help in correlating genotype with phenotype in Pelizaeus-Merzbacher disease/X-linked spastic paraplegia (PMD/SPG2).
|
9934976 |
1999 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Pelizaeus-Merzbacher disease (PMD) is a leukodystrophy associated with mutations in the proteolipid protein (PLP) gene.
|
10401787 |
1999 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Increased dosage of the proteolipid protein (Plp) gene causes CNS disease (Pelizaeus-Merzbacher disease [PMD]), which has many similarities to disorders of the PNS associated with duplication of the peripheral myelin protein-22 (PMP22) gene locus.
|
10586248 |
1999 |
Pelizaeus-Merzbacher Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
The myelin proteolipid protein (PLP) gene (i.e., the PLP/DM20 gene) has been of some interest because of its role in certain human demyelinating diseases, such as Pelizaeus-Merzbacher disease.
|
10493736 |
1999 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Pelizaeus-Merzbacher disease (PMD) is a dysmyelinating disorder of the central nervous system typically caused by duplications or missense mutations of the proteolipid protein (PLP) gene.
|
10586260 |
1999 |
Pelizaeus-Merzbacher Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Duplications of the proteolipid protein (PLP) gene have been found in a proportion of patients, suggesting that, in addition to coding-region or splice-site mutations, overdosage of the gene can cause PMD.
|
9634530 |
1998 |